HUP9903115A2 - Vizes közegben duzzadó mátrixban legalább egyféle gyógyászati hatóanyagot tartalmazó orális készítmény - Google Patents

Vizes közegben duzzadó mátrixban legalább egyféle gyógyászati hatóanyagot tartalmazó orális készítmény

Info

Publication number
HUP9903115A2
HUP9903115A2 HU9903115A HUP9903115A HUP9903115A2 HU P9903115 A2 HUP9903115 A2 HU P9903115A2 HU 9903115 A HU9903115 A HU 9903115A HU P9903115 A HUP9903115 A HU P9903115A HU P9903115 A2 HUP9903115 A2 HU P9903115A2
Authority
HU
Hungary
Prior art keywords
swelling
aqueous medium
active pharmaceutical
preparation containing
oral preparation
Prior art date
Application number
HU9903115A
Other languages
English (en)
Inventor
Karsten Cremer
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh filed Critical Lts Lohmann Therapie-Systeme Gmbh
Publication of HUP9903115A2 publication Critical patent/HUP9903115A2/hu
Publication of HUP9903115A3 publication Critical patent/HUP9903115A3/hu
Publication of HU227865B1 publication Critical patent/HU227865B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Orális készítmény, amely legalább egyfajta gyógyászati hatóanyagőttartalmazó, vizes közegben dűzzadó mátrixőt tartalmaz és ez ahatóanyag a mátrixból annak dűzzadása sőrán időben elnyújtőttanszabadűl fel a vizes közegbe, miközben e felszabadítás sőránmesszemenően ellenáll a szétesésnek, amelyre jellemző, hőgy akészítmény egymásra tapadó rétegekből álló réteges tabletta, amelybenleglaább egy réteget az említett mátrixréteg képez, legalább egytővábbi réteg pedig segéd- és/vagy hőrdőzóanyag réteg, mimellett adűzzadó mátrixréteg a hatóanyag mellett térhálósítőtt amilózt istartalmaz. ŕ
HU9903115A 1996-09-28 1997-08-29 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium HU227865B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19640062A DE19640062B4 (de) 1996-09-28 1996-09-28 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff

Publications (3)

Publication Number Publication Date
HUP9903115A2 true HUP9903115A2 (hu) 2000-02-28
HUP9903115A3 HUP9903115A3 (en) 2000-03-28
HU227865B1 HU227865B1 (en) 2012-05-29

Family

ID=7807265

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903115A HU227865B1 (en) 1996-09-28 1997-08-29 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium

Country Status (23)

Country Link
US (1) US6238698B1 (hu)
EP (1) EP0946150B1 (hu)
JP (1) JP2001504807A (hu)
KR (1) KR100493139B1 (hu)
CN (1) CN1139378C (hu)
AT (1) ATE213933T1 (hu)
AU (1) AU724802B2 (hu)
CA (1) CA2260845C (hu)
CZ (1) CZ291258B6 (hu)
DE (2) DE19640062B4 (hu)
DK (1) DK0946150T3 (hu)
ES (1) ES2174296T3 (hu)
HU (1) HU227865B1 (hu)
IL (1) IL129171A (hu)
MY (1) MY130959A (hu)
NO (1) NO991477L (hu)
NZ (1) NZ333401A (hu)
PL (1) PL188392B1 (hu)
PT (1) PT946150E (hu)
SI (1) SI0946150T1 (hu)
SK (1) SK282709B6 (hu)
WO (1) WO1998013028A1 (hu)
ZA (1) ZA978625B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
BRPI0615860B8 (pt) 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US8226967B2 (en) 2008-11-27 2012-07-24 Basf Se Surface active proteins as excipients in solid pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
WO1994002121A1 (en) * 1992-07-24 1994-02-03 Labopharm Inc. Cross-linked polyhydroxylic material for enzymatically controlled drug release
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4416926C2 (de) 1994-05-13 2000-01-13 Lohmann Therapie Syst Lts Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
WO2007095324A1 (en) 2006-02-14 2007-08-23 The Procter & Gamble Company Personal care compositions comprising responsive particles

Also Published As

Publication number Publication date
JP2001504807A (ja) 2001-04-10
WO1998013028A1 (de) 1998-04-02
SI0946150T1 (en) 2002-08-31
EP0946150B1 (de) 2002-03-06
HUP9903115A3 (en) 2000-03-28
DE19640062B4 (de) 2006-04-27
NO991477D0 (no) 1999-03-26
SK38799A3 (en) 2000-03-13
IL129171A (en) 2001-11-25
DK0946150T3 (da) 2002-06-24
CA2260845A1 (en) 1998-04-02
PL332577A1 (en) 1999-09-27
AU724802B2 (en) 2000-09-28
US6238698B1 (en) 2001-05-29
HU227865B1 (en) 2012-05-29
CN1231600A (zh) 1999-10-13
SK282709B6 (sk) 2002-11-06
ATE213933T1 (de) 2002-03-15
NO991477L (no) 1999-03-26
PT946150E (pt) 2002-08-30
CA2260845C (en) 2005-11-22
CZ101399A3 (cs) 1999-07-14
CN1139378C (zh) 2004-02-25
PL188392B1 (pl) 2005-01-31
CZ291258B6 (cs) 2003-01-15
NZ333401A (en) 1999-10-28
IL129171A0 (en) 2000-02-17
DE19640062A1 (de) 1998-04-09
EP0946150A1 (de) 1999-10-06
AU4619397A (en) 1998-04-17
KR100493139B1 (ko) 2005-06-02
ZA978625B (en) 1998-03-26
ES2174296T3 (es) 2002-11-01
DE59706576D1 (de) 2002-04-11
KR20010029533A (ko) 2001-04-06
MY130959A (en) 2007-07-31

Similar Documents

Publication Publication Date Title
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AU610112B2 (en) Tablet for pharmaceutical use able to release active substances at successive times
PL329285A1 (en) Pharmaceutic tablets of controllable active substance release containing an active substance carrier based on crosslinked amylase and hydroxypropylmethylllcellulose
GR3003031T3 (en) Granule remaining in stomach
EP0356382A3 (de) Mehrschichtiges Pflaster
ITMI922617A1 (it) Forme matriciali multistrato per il rilascio controllato di principi attivi
FI944035A (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
ZA977832B (en) Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents.
AU1023788A (en) Therapeutic system for sparingly soluble active ingredients
AU3268689A (en) Transdermal monolith systems
ES2182397T3 (es) Comprimido para la liberacion instantanea y prolongada de una o mas substancias activas.
NZ298994A (en) Drug dosage form containing a core having at least two layers, both containing a polymer that forms microscopic gel beads upon hydration but only one contains the drug and an impermeable, insoluble coating containing apertures which provide for the hydration and release of the beads
IL129171A0 (en) Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
CA2283408A1 (en) Swallow tablet comprising paracetamol
DK0615442T3 (da) Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.
EP0070127A3 (en) Tablets
WO1994025025A3 (de) Systeme zur kontrollierten abgabe von pilocarpin
ES8603262A1 (es) Perfeccionamientos en formas farmaceuticas solidas para uso oral
EP0974361A4 (en) METHOD OF USING AN ANTI-ACID AGENT AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény
IT1275267B (it) Forme farmaceutiche a rilascio modificato di canrenoato di potassio costituite da matrici idrofile rivestite
AU4015097A (en) Transdermal therapeutic system having an active compound combination comprising oestriol

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees